Big revenue generator
“The Lercanidipine products have been and continue to be, the biggest revenue generator for the Recordati group, and that revenue has helped fuel the global expansion of the group since the ’90s,” Dr Kilkelly explains.
Over the past two years, production capacity at the Cork plant has grown by more than 30%, primarily due to a range of locallydriven, and highly-successful, initiatives.
“In addition, last year we spent some €1 million on expanding our offices and laboratories in anticipation of increased demands for our products,” says Dr Kilkelly.
The drivers of this increase are the International Sales team who are based in Cork and have the strong support of a multi-disciplinary team in Cork. This activity is of equal strategic importance and is growing rapidly. Cork has a number of key global management and distribution functions — staff at Ringaskiddy are responsible for marketing, business development, finance, supply chain and contract management for a large portfolio of its products in 90 countries around the world.
A strong Irish sales team is also based in Cork and in the Irish market, Recordati focuses on drugs for the treatment of conditions in the areas of urology (Urorec, Urispas, Kentera), cardiology (Zanidip, Lercaril) and gastro-intestinal treatment ( Cleenema, Citrafleet, Phosphosoda) and has also recently launched Vitaros, an innovative product for the treatment of erectile dysfunction.
Not surprisingly, given the scale of its international reach, the Recordati Ireland campus has a cosmopolitan atmosphere, and it features staff from Mexico, Spain, France, Italy, Belgium, Ukraine, Poland, Serbia and of course Ireland.
Dr Kilkelly said: “The majority of our workforce is Irish but we have a significant proportion of employees coming from around the world.
“We have a multi-lingual, multicultural environment which is important for our international business, but also creates a wonderful, diverse, creative atmosphere for everyone. It truly reflects the inclusiveness of modern Ireland,” he said.
In all, 64 people are em- ployed at the Ringaskiddy facility in a number of activities says Dr Kilkelly who anticipates, that as a result of the company’s strong, ongoing growth — globally, Recordati employs more than 4,000 people — the Cork workforce will grow steadily over the next few years.
This growth has been led by a multidisciplinary management team: Antoine Groues (former VP and di- rector of International Sales); Kevin Buckley (Country Operations Director); Nelson Pires (Director Ireland Market) as well as Michael Kilkelly ( Plant Manager).
However, there are concerns, that at a local level, connectivity is becoming a concern.
“Traffic in Ringaskiddy is becoming a problem. As more and more companies
Michael Kilkelly, Plant Manager and Director, Recordati, Raheens East, Ringaskiddy, Co Cork.
Kevin Buckley, country operations director, with Michael Kilkelly, plant manager and director, with (rear) the international sales team of Gilles Luquet, Luigi Quaglia, Maurizio Gaiani, and David O’Sullivan, at Recordati, Raheens East, Ringaskiddy, Co Cork.
Reception area and administration building at Recordati, Cork.